Share this
clinical trials: the challenge of subject retention
by Neoteryx on Apr 23, 2019 4:20:00 AM
Clinical trials are one of the most important elements in research and modern healthcare. It is through clinical trials that medications are tested and their effectiveness established. Without the trials, it would be challenging to make any modern-day medical breakthroughs.
Like any other research field, clinical trials face a number of challenges. Recruitment and retention of patients for clinical trials is one very challenging aspect. There are several reasons why subject retention is challenging. They include:
1. Most clinical trials have a small population of patients with conditions being investigated. Once they've been found, it can be hard to keep them engaged. One reliable means of finding and keeping patients who are willing to participate in these trials is making the research public. Once the patients are there, it’s important to let them know everything there is to know (that is reasonable to reveal to the patient) about the research. A training session in which the patients meet the scientists they will be working with is sometimes appropriate. It would help patients know what is expected of them and why they're doing this.
2. There is often a fear of side effects. This can lead to patients dropping out of the research. This usually affects patients at the initial stage of the study just before the trials start. It is often a psychological factor and can be eased by creating awareness. Information helps put the patients’ minds at ease and lets them know what to expect. Once the trials start, the patients do not drop out of the study because of uncertainty; they already know what to expect.
3. It is difficult to retain patients once the trials have started if the patient’s circumstances change. For example, a patient’s family may decide to relocate while the study is ongoing. An unforeseen distance barrier might make it difficult for a patient to continue participating in the trials.
4. Finally, the fear of study procedures may result in patients dropping out. Procedures such constant blood draws could be minimized by using patient-friendly tools that can improve their experience. These are new tools such as microsampling, which allows collection of very small amounts of blood. Incentives for patients participating may help retain them. In an increasing number of cases, remote monitoring through remote sampling may also be an option.
Share this
- Alternative to Venipuncture (95)
- Clinical Trials (54)
- Capillary Blood Sampling (34)
- Remote Blood Collection (28)
- Alternative to Dried Blood Spot (27)
- research studies (24)
- Microsampling (22)
- Immunosuppressants (17)
- Coronavirus (16)
- RNA / DNA from Dried Blood (13)
- finger-stick microsampling (11)
- remote microsampling (11)
- therapeutic drug monitoring (10)
- COVID-19 (8)
- Viral Pathogens (8)
- remote microsampling study (8)
- Blood Collection At Home (7)
- remote specimen collection (7)
- SARS-CoV-2 (6)
- specimen collection (6)
- clinical research (5)
- Blood Sampling (4)
- Pharmacokinetics (4)
- Antibodies (3)
- anti-doping (3)
- anticancer (3)
- blood samples (3)
- coronavirus pandemic (3)
- home blood collection (3)
- microbiopsy (3)
- remote research studies (3)
- remote technologies (3)
- cannabis and cannabinoids (2)
- dried blood (2)
- mAbs (2)
- pediatric clinical trials (2)
- serology studies (2)
- DBS (1)
- Education (1)
- Extractions / Sample Prep (1)
- Genetic Profiling (1)
- Immunoassay (1)
- PEth (1)
- Sample Storage (1)
- antiepileptics (1)
- biospecimen collection (1)
- blood collection (1)
- clinical trial monitoring (1)
- creatinine (1)
- drug monitoring (1)
- genetic fingerprinting (1)
- heavy metal exposure (1)
- heavy metal poisoning (1)
- heavy metals (1)
- hormones (1)
- infectious disease studies (1)
- labs (1)
- molecular research (1)
- remote blood sampling (1)
- skin biopsy (1)
- tacrolimus (1)
- virtual clinical trials (1)
- February 2023 (1)
- January 2023 (3)
- December 2022 (2)
- November 2022 (3)
- October 2022 (4)
- September 2022 (3)
- August 2022 (5)
- July 2022 (2)
- June 2022 (2)
- May 2022 (4)
- April 2022 (3)
- March 2022 (3)
- February 2022 (4)
- January 2022 (5)
- December 2021 (3)
- November 2021 (5)
- October 2021 (3)
- September 2021 (3)
- August 2021 (4)
- July 2021 (4)
- June 2021 (4)
- May 2021 (4)
- April 2021 (3)
- March 2021 (5)
- February 2021 (4)
- January 2021 (4)
- December 2020 (3)
- November 2020 (5)
- October 2020 (4)
- September 2020 (3)
- August 2020 (3)
- July 2020 (6)
- June 2020 (4)
- May 2020 (4)
- April 2020 (3)
- March 2020 (6)
- February 2020 (3)
- January 2020 (4)
- December 2019 (5)
- November 2019 (6)
- October 2019 (4)
- September 2019 (5)
- August 2019 (5)
- July 2019 (4)
- June 2019 (7)
- May 2019 (6)
- April 2019 (5)
- March 2019 (6)
- February 2019 (6)
- January 2019 (8)
- December 2018 (4)
- November 2018 (4)
- October 2018 (7)
- September 2018 (8)
- August 2018 (6)
- July 2018 (8)
- June 2018 (6)
- May 2018 (5)
- April 2018 (6)
- March 2018 (5)
- February 2018 (7)
- January 2018 (4)
- December 2017 (2)
- November 2017 (3)
- October 2017 (2)
- September 2017 (5)
- August 2017 (2)
- July 2017 (4)
- June 2017 (5)
- May 2017 (6)
- April 2017 (6)
- March 2017 (5)
- February 2017 (4)
- January 2017 (1)
- July 2016 (3)
- May 2016 (1)
- April 2016 (2)
No Comments Yet
Let us know what you think